This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Widjaja, A. Articles by Brabant, G. Search for Related Content PubMed PubMed Citation Articles by Widjaja, A. Articles by Brabant, G.

Determinants of Serum Leptin Levels in Cushing’s Syndrome

Department of Clinical Endocrinology, Medizinische Hochschule Hannover (A.W., T.H.S., A.V.Z.M., G.B.), Hannover; and the Department of Endocrinology and Metabolism, FPP, Trier University (T.H.S.), Trier, Germany

Address all correspondence and requests for reprints to: Dr. A. Widjaja, Department of Clinical Endocrinology, Medizinische Hochschule Hannover, D-30623 Hannover, Germany. E-mail: ndxdadji{at}rrzn-serv.de

Corticosteroids and insulin increase leptin expression in vivo and in vitro. To investigate whether increased serum cortisol influences serum leptin concentrations in humans, we analyzed fasting serum leptin and insulin levels in 50 patients with Cushing’s syndrome [34 female patients: 27 with the pituitary form and 7 with the adrenal form; age, 41.6 ± 2.7 yr; body mass index (BMI), 29.6 ± 1.2 kg/m²; 16 male patients all with the pituitary form; age, 39.2 ± 3.1 yr; BMI, 26.3 ± 2.3 kg/m²] and in controls matched for BMI, age, and gender. Serum leptin levels were higher in female than in male patients in both the Cushing (P < 0.01) and control (P < 0.001) groups. Disease-specific differences in serum leptin levels were only detected in male (106 vs. 67 pmol/L; Cushing’s syndrome vs. control, P < 0.05), not female, patients. Multiple stepwise regression analysis of both patient groups revealed insulin as the best predictor of serum leptin concentrations, accounting for 37% of the variance in serum leptin levels, in contrast to BMI or mean serum cortisol (as measured by sampling in 10-min intervals over 24 h). In the subgroup of patients (n = 9) with pituitary adenoma, serum leptin levels were reduced after tumor resection, with concurrent decreases in serum cortisol, insulin, and BMI. In conclusion, chronic hypercortisolemia in Cushing’s syndrome appears not to directly affect serum leptin concentrations, but to have an indirect effect via the associated hyperinsulinemia and/or impaired insulin sensitivity.

This article has been cited by other articles:

				S. S. Damjanovic, N. M. Lalic, P. M. Pesko, M. S. Petakov, A. Jotic, D. Miljic, K. S. Lalic, L. Lukic, M. Djurovic, and V. B. Djukic Acute Effects of Ghrelin on Insulin Secretion and Glucose Disposal Rate in Gastrectomized Patients J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2574 - 2581. [Abstract] [Full Text] [PDF]

				L. R. Gentry, D. L. Thompson Jr., G. T. Gentry Jr., K. A. Davis, and R. A. Godke High versus low body condition in mares: Interactions with responses to somatotropin, GnRH analog, and dexamethasone J Anim Sci, December 1, 2002; 80(12): 3277 - 3285. [Abstract] [Full Text] [PDF]

				E. Charmandari, M. Weise, S. R. Bornstein, G. Eisenhofer, M. F. Keil, G. P. Chrousos, and D. P. Merke Children with Classic Congenital Adrenal Hyperplasia Have Elevated Serum Leptin Concentrations and Insulin Resistance: Potential Clinical Implications J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2114 - 2120. [Abstract] [Full Text] [PDF]

				P. J. Havel Peripheral Signals Conveying Metabolic Information to the Brain: Short-Term and Long-Term Regulation of Food Intake and Energy Homeostasis Experimental Biology and Medicine, December 1, 2001; 226(11): 963 - 977. [Abstract] [Full Text] [PDF]

				B. V. Zlokovic, S. Jovanovic, W. Miao, S. Samara, S. Verma, and C. L. Farrell Differential Regulation of Leptin Transport by the Choroid Plexus and Blood-Brain Barrier and High Affinity Transport Systems for Entry into Hypothalamus and Across the Blood-Cerebrospinal Fluid Barrier Endocrinology, April 1, 2000; 141(4): 1434 - 1441. [Abstract] [Full Text] [PDF]

				M. Weise, V. Abad, R. V. Considine, L. Nieman, and K. I. Rother Leptin Secretion in Cushing's Syndrome: Preservation of Diurnal Rhythm and Absent Response to Corticotropin-Releasing Hormone J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2075 - 2079. [Abstract] [Full Text]